WEDNESDAY 22 MARCH 2006

14.00-15.30 Scientific and Practice sessions and Industry-sponsored satellite symposia

Seminar 11: National Presidents Symposium: local initiatives on patient safety that will work tomorrow in your hospital / Level: Introductory
Speaker A: Martin Schuitenmaker PharmD, President Dutch hospital pharmacists association
Speaker B: Anne Helene Kahns PharmD PhD, President Danish hospital pharmacists association
Speaker C: Jan Petracek, PhD, President Czech hospital pharmacists association

Seminar 3: The realities facing the development of an integrated automated medication system in hospitals; achievable or impossible? / Level: Advanced
Speaker A: William Churchill, Director of Pharmacy, The Brigham and Women's Hospital, Boston, USA
Speaker B: Karen Marie Østergaard, Pharmacist, Head of Hospital Pharmacy Department, Skejby Hospital, Arhus, Denmark

Seminar 6: TPN for neonates: evolution over 30 years / Level: Advanced
Speaker A: Professor Stefan Mühlebach, Swissmedic, Bern, Switzerland
Speaker B: Professor Olivier Goulet, Necker Hospital, Paris, France

Seminar 10: 'Drug distribution on trial - is unit dose the correct way forward? / Level: Intermediate
Speaker A: Michael Cross, Barts & The London NHS Trust, London, UK
Speaker B: Professor Nick Barber, School of Pharmacy University of London, London, UK
Speaker C: Rob Janknegt, PharmD PhD, Maaslandziekenhuis Sittard,The Netherlands

15.30-16.00 Coffee break and poster session

16.00-17.30 Scientific and Practice sessions and Industry-sponsored satellite symposia

Seminar 1: The need for drug information exchange across European countries: creating a European information service network / Level: Intermediate
Speaker A: David Erskine, BPharm MSc MRPharmS, London and South East Regional Medicines Information Service, London, UK
Speaker B: Allan Schrøder, M.Sc. Pharm, H:S Pharmacy, Copenhagen, Denmark

Seminar 4: Stability of injectable drugs / Level: Advanced
A. What are causes for concern and what solutions are possible?
Speaker: Tim Root, Clinical Governance & Technical Services, Chelsea & Westminster Hospital, London, UK
B. How to establish stability on a reconstituted injectable properly?
Speaker: Jean Vigneron, PharmD PhD, Centre Hospitalier Universitaire, Nancy, France
C. Results from microbiological stability in cytotoxics and its implications for the practice
Speaker: Irene Krämer, PharmD PhD, Klinikum der Johannes Gutenberg Universität, Mainz, Germany

Seminar 9: Modern imaging technology in drug research and development / Level: Advanced
Speakers: Professor Juhani Knuuti and Professor Harry Scheinin, Turku PET Centre, University of Turku, Turku, Finland

18.00-20.00 Opening Ceremony

Keynote presentation
Quality of pharmaceutical services: a tool to help improve the safety of the medication process?
Speaker: Johnny Beney, ICHV Pharmacy, Sion, Switzerland

20.00-21.00 Welcome reception and opening of the exhibition

THURSDAY 23 MARCH 2006

09.00-10.30 Scientific and Practice sessions and Industry-sponsored satellite symposia

Seminar 2: Documenting pharmacist interventions (to illustrate staff needs and manage human resources) / Level: Intermediate
Speaker A: Roger Williams, Pharmacy Manager, Morriston Hospital, Swansea, UK
Speaker B: Dr. Steffen Amann, Klinikum MRI, Technische Universität München, Germany

Seminar 4: Stability of injectable drugs / Level: Advanced
A. What are causes for concern and what solutions are possible?
Speaker: Tim Root, Clinical Governance & Technical Services, Chelsea & Westminster Hospital, London, UK
B. How to establish stability on a reconstituted injectable properly?
Speaker: Jean Vigneron, PharmD PhD, Centre Hospitalier Universitaire, Nancy, France
C. Results from microbiological stability in cytotoxics and its implications for the practice
Speaker: Irene Krämer, PharmD PhD, Klinikum der Johannes Gutenberg Universität, Mainz, Germany

Seminar 9: Modern imaging technology in drug research and development / Level: Advanced
Speakers: Professor Juhani Knuuti and Professor Harry Scheinin, Turku PET Centre, University of Turku, Turku, Finland

Seminar 11: National Presidents Symposium: local initiatives on patient safety that will work tomorrow in your hospital / Level: Introductory
Speaker A: Martin Schuitenmaker PharmD, President Dutch hospital pharmacists association
Speaker B: Anne Helene Kahns PharmD PhD, President Danish hospital pharmacists association
Speaker C: Jan Petracek, PhD, President Czech hospital pharmacists association

10.30-11.30 Coffee break and poster session

11.30-12.30 Keynote presentation
Clinical pharmacology: drug action in progressing disease
Speaker: Dr Diane Mould, Projections Research Inc., Phoenixville, USA

12.30-14.00 Lunch

14.00-15.30 Scientific and Practice sessions and Industry-sponsored satellite symposia

Seminar 1: The need for drug information exchange across European countries: creating a European information service network / Level: Intermediate
Speaker A: David Erskine, BPharm MSc MRPharmS, London and South East Regional Medicines Information Service, London, UK
Speaker B: Allan Schrøder, M.Sc. Pharm, H:S Pharmacy, Copenhagen, Denmark

Seminar 3: The realities facing the development of an integrated automated medication system in hospitals; achievable or impossible? / Level: Advanced
Speaker A: William Churchill, Director of Pharmacy, Brigham and Womens' Hospital, Boston, USA
Speaker B: Karen Marie Østergaard, Pharmacist, Head of Hospital Pharmacy Department, Skejby Hospital, Århus, Denmark

Seminar 8: Evidence based drug formularies (How to produce a drug information document to support the decisions of therapeutic committee/hospital formulary committee) / Level: Intermediate
A. Why do we need it?
Speaker: Roger Walker, BPharm PhD, Professor of Pharmacy and Consultant in Pharmaceutical Public Health, Cardiff, UK
B. Technology of drug selection
Speaker: Rob Janknegt, PharmD PhD, Maaslandziekenhuis Sittard,The Netherlands
C. Practical applications
Speaker: Michael Scott, PhD, Antrim Area Hospital, Antrim, Northern Ireland

Seminar 12: Software interfacing in seamless pharmaceutical care: from Babel Tower to smooth communication/ Level: Introductory
Speaker A: Franck Gener, Association "réseau Phast", Armentieres, France
Speaker B: Julie James, MRPharmS, Blue Wave Informatics LLP, Exeter, UK
Speaker C: Simon Letellier, Centre Hospitalier Spécialisé de la Sarthe, France

15.30-16.00 Coffee break and poster session

16.00-17.30 Scientific and Practice sessions and Industry-sponsored satellite symposia

Seminar 5: European GMP-standards for compounding and reconstitution: compatible with routine patient oriented pharmacy? / Level: Advanced
Speaker A: Lloyd Allen, PhD, International Journal of Pharmaceutical Compounding, Oklahoma, United States
Speaker B: Andras Vermes, PharmD PhD, Erasmus University Medical Center, Rotterdam,The Netherlands

Seminar 6: TPN for neonates: evolution over 30 years / Level: Advanced
Speaker A: Professor Stefan Mühlebach, Swissmedic, Bern, Switzerland
Speaker B: Professor Olivier Goulet, Necker Hospital, Paris, France

Seminar 7: Barcode and Radio Frequency Identification (RFID) scanning: from theory to reality / Level: Intermediate
A. Technical principles: from the identification to the expression
Speaker: Christian Hay, GS1 Europe’s Healthcare Initiative (GS1, formerly EAN International), Rolle, Switzerland
B. Application of scanning technologies to the medication process
Speaker: Michael Baehr, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Seminar 10: 'Drug distribution on trial - is unit dose the correct way forward?/ Level: Intermediate
Speaker A: Michael Cross, Barts & The London NHS Trust, London, UK
Speaker B: Professor Nick Barber, School of Pharmacy University of London, London, UK
Speaker C: Rob Janknegt, PharmD PhD, Maaslandziekenhuis Sittard,The Netherlands

FRIDAY 24 MARCH 2006

09.00-10.30 Scientific and Practice sessions and Industry-sponsored satellite symposia

Seminar 2: Documenting pharmacist interventions (to illustrate staff needs and manage human resources) / Level: Intermediate
Speaker A: Roger Williams, Pharmacy Manager, Morriston Hospital, Swansea, UK
Speaker B: Dr. Steffen Amann, Klinikum MRI, Technische Universität Muenchen, Germany

Seminar 5: European GMP-standards for compounding and reconstitution: compatible with routine patient oriented pharmacy? / Level: Advanced
Speaker A: Lloyd Allen, PhD, International Journal of Pharmaceutical Compounding, Oklahoma, United States
Speaker B: Andras Vermes, PharmD PhD, Erasmus University Medical Center, Rotterdam,The Netherlands

Seminar 7: Barcode and Radio Frequency Identification (RFID) scanning: from theory to reality / Level: Intermediate
A. Technical principles: from the identification to the expression
Speaker: Christian Hay, GSI Europe's Healthcare Initiative (GS1, formerly EAN International), Rolle, Switzerland
B. Application of scanning technologies to the medication process
Speaker: Michael Baehr, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Seminar 8: Evidence based drug formularies (How to produce a drug information document to support the decisions of therapeutic committee/hospital formulary committee) / Level: Intermediate
A. Why do we need it?
Speaker: Roger Walker, BPharm PhD, Professor of Pharmacy and Consultant in Pharmaceutical Public Health, Cardiff, UK
B. Technology of drug selection
Speaker: Rob Janknegt, PharmD PhD, Maaslandziekenhuis Sittard,The Netherlands
C. Practical applications
Speaker: Michael Scott, PhD, Antrim Area Hospital, Antrim, Northern Ireland

Seminar 12: Software interfacing in seamless pharmaceutical care: from Babel Tower to smooth communication/ Level: Introductory
Speaker A: Franck Gener, Association "r'seau Phast", Armentieres, France
Speaker B: Julie James, MRPharmS, Blue Wave Informatics LLP, Exeter, UK
Speaker C: Simon Letellier, Centre Hospitalier Specialise de la Sarthe, France

10.30-11.30 Coffee break and poster session

11.30-12.30 Keynote presentation
Risk management in hospital pharmacy
Speaker: Cathy Mooney, Clinical Governance Manager, Charing Cross Hospital, London, UK

12.30-14.00 Closing Ceremony and Lunch

Scientific Committee:
Chairman: Professor Arnold Vulto (The Netherlands);
Members: Dr. Pascal Bonnabry (Switzerland), Dr. Marcela Heislerova (Czech Republic), Dr. Torsten Hoppe-Tichy (Germany), Mr Robert McArtney (UK), Mr Bror-Lennart Mentzoni (Norway), Dr. Maria Skouroliakou (Greece), Dr. Kirsti Torniainen (Finland)

Quality and Medication Safety Hand in Hand

From the early days of pharmacy, quality assurance and the development of standards have been integral parts of the pharmaceutical profession. As long as pharmacy has existed, there have also existed codices, pharmacopoeias, etc., in which pharmacists tried to describe their quality standards. It seems that pharmacist almost invented the principles of quality management in the early days. It is fun to look in such old books. Even during the last century, tests were described in which one took a certain number of insects, treated them with a known concentration of a drug, put them on their back and counted how many could stand up and fly again, and how long that took. Or take a dozen rabbits, inject them with an infusion fluid, and see whether they developed fever: a real dynamic test for the presence or absence of pyrogens. Actually, both are elegant examples of pharmaco-dynamic experiments, likely to be more meaningful in real life than the modern HPLC-MS machines, which produce beautiful printouts, whereas their direct meaning for patient care is sometimes rather remote. Nevertheless, the European Pharmacopoeia is very much alive and still serves us well by developing important and timely quality standards for pharmacy. But hospital pharmacy has moved on... Who has been reading the Ph Eur, 5th edition, during the past few months? So, has the quality gone? Not at all: with the same rigour as pharmacists have developed quality standards for their products, they are now developing quality standards for their services: starting with therapeutic drug monitoring, followed by drug distribution, drug information, patient care and the other clinical tasks in which hospital pharmacists are becoming involved more and more frequently.
Drug treatment is also becoming even more complicated and, in many cases, also more risky with modern very potent or interaction-prone drugs. In many countries, medication safety has become a topic of national concern. It is only natural that pharmacists should apply their traditional skills in quality management to this more recent area of pharmacy activities: quality and medication safety hand in hand.

Professor Arnold G. Vulto
Chairman Scientific Committee